| ㆍGeneral Introduction |
Customer is currently searching for partners with good local, regional or international territorial coverage to involve in early Pre-Marketing phase and the subsequent Launch and Rapid Market Entry for a NEW AIDS Drug, a nucleoside analogue reverse transcriptase inhibitor (NRTI) for patients failing their current therapy because of resistance or intolerance.
- Retains activity in HIV patients who have developed resistance to other products
- All data have been reviewed by the FDA
- Excellent Clinical Data: successfully completed 6 Phase I, 2 Phase II, 1 Phase IIb studies |
| ㆍMechanism of Action |
|
| ㆍIndication |
|
| ㆍBusiness Type |
| The company is looking for licensing partner in each country. |
|
